查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1871852

全球微生物护肤品市场：预测至2032年－按产品、成分类型、通路、应用、最终用户和地区进行分析

Microbiome Skincare Products Market Forecasts to 2032 - Global Analysis By Product (Serums Creams and Lotions, Masks, Cleansers, Toners, Sunscreens and Other Products), Ingredient Type, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，预计到 2025 年，全球微生物组护肤品市场价值将达到 19 亿美元，到 2032 年将达到 60 亿美元，在预测期内的复合年增长率为 17.8%。

微生物组护肤产品旨在维持和恢復皮肤表面细菌、真菌、病毒和其他微生物的天然平衡。这些产品支持健康的皮肤微生物组，而健康的皮肤微生物组在抵抗病原体、调节发炎和维持皮肤屏障方面发挥关键作用。透过利用益生元、益生菌和后生元，微生物组护肤护肤能够促进有益微生物的生长，同时最大限度地减少有害微生物。这种方法可以增强肌肤的韧性、保湿能力和整体健康，特别适用于敏感肌、易长痘肌或老龄化肌肤。其目标是实现皮肤与其微生物生态系统之间的和谐，从而达到最佳的皮肤功能和外观。

微生物组科学、检测和製剂技术进展

研究人员正在揭示皮肤微生物群与痤疮、湿疹和老化等皮肤问题之间的联繫，这推动了对针对性解决方案的需求。该平台支持益生元、益生菌和后生元成分，这些成分能够恢復皮肤平衡并强化皮肤屏障。结合体学检测、人工智慧配方和个人化护肤，可以提高功效并实现差异化。在皮肤科、健康和美容领域，对科学验证、温和且能增强皮肤屏障的产品的需求正在增长。这些趋势正在推动以微生物群为基础的平台在整个护肤系统中的应用。

消费者对各种说法感到困惑与怀疑

许多使用者难以理解成分功能、产品作用机制和临床意义，导致参与度和忠诚度较低。企业在检验产品功效、与传统护肤分开来以及传达产品益处方面面临诸多挑战。缺乏标准化的标籤、第三方认证和教育进一步阻碍了产品的普及和信誉。供应商必须投资于透明的通讯、临床试验以及与皮肤科医生的合作，才能建立信任。这些限制因素持续阻碍以认知驱动和科学为导向的护肤市场平台的成熟。

皮肤疾病增多，人们对皮肤屏障功能的兴趣日益浓厚

消费者越来越倾向于寻求解决痤疮、敏感肌肤、干燥以及与微生物群失衡相关的发炎等问题。该平台采用标靶微生物来源成分，提供强化肌肤屏障、保湿和抗炎功效。结合健康生活方式、远距皮肤科咨询和生活方式评估，可提高个人化和有效性。年轻肌肤、老龄化和敏感肌肤等不同肤质族群对温和、全面且经临床检验的产品需求日益增长。这些趋势正在推动强化肌肤屏障和针对症状的微生物群护肤平台的发展。

监管方面的不确定性和缺乏统一的指导方针

益生菌、益生元和后生元的定义因地区而异，这使得配方和市场推广变得复杂。企业在应对化妆品、药品和膳食补充剂监管法规的同时，还需保持创新并快速推向市场，无疑是一项挑战。缺乏统一的标准和针对微生物组的框架，导致核准延迟，并阻碍了跨境扩张。供应商必须透过与监管机构合作、投资安全文件以及与新兴的微生物组认证机构建立伙伴关係来降低风险。这些限制因素持续制约着合规性驱动、跨司法管辖区的护肤市场平台的绩效。

新冠疫情的感染疾病：

疫情加速了人们对皮肤健康、免疫力和整体健康的关注，推动了全球市场对微生物组护肤的接受度。封锁措施中断了人们去美容院的次数，增加了居家屏障修护和舒缓压力护肤的需求。各大平台迅速扩展了益生菌精华液、注重微生物组的洗面乳和数位皮肤诊断服务。品牌、零售商和Start-Ups在电子商务、远距皮肤科咨询和个人化护肤领域的投资激增。媒体和消费者群体对皮肤微生物组及其在发炎和皮肤韧性方面的作用的认知度也随之提高。这些转变正在增强人们对利用微生物组技术的健康护肤平台的长期投资。

预计益生菌细分市场在预测期内将占据最大的市场份额。

由于益生菌产品用途广泛、功效显着，且消费者对微生物组护肤的认知度较高，预计在预测期内，益生菌细分市场将占据最大的市场份额。该平台利用活菌或裂解菌来增强皮肤屏障功能、减少发炎并改善肤质。与精华液、面膜和保湿霜的结合使用，可提高渗透性和日常使用的兼容性。在易长痘痘、老龄化和敏感肌肤等不同肤质族群中，对经临床检验、温和且能平衡微生物组的产品需求日益增长。供应商提供针对特异性菌株的配方、经皮肤科医生认可的功效声明以及透明的成分来源，以推动产品的普及。这些优势正在巩固益生菌细分市场在整个主导护肤平台中的主导地位。

预计痤疮治疗领域在预测期内将实现最高的复合年增长率。

在预测期内，抗痘领域预计将迎来最高的成长率，这主要得益于旨在减少发炎、调节皮脂分泌和修復皮肤屏障的微生物组平台的扩张。这些产品针对引起痤疮的细菌，同时保护有益微生物，从而减少刺激和復发。相关平台可支援局部治疗、洗面乳和精华液等产品，以解决由荷尔蒙压力和生活习惯引起的痤疮。与远距皮肤科咨询、穿戴式诊断设备和个人化护肤方案的整合将提升产品的有效性和普及率。青少年、成年人和后疫情时代的护肤消费者对非抗生素、温和且对微生物组安全的护肤方案的需求日益增长。这些趋势正在推动专注于痤疮治疗的微生物组护肤平台和服务的发展。

占比最大的地区：

预计在预测期内，北美将占据最大的市场份额，这主要得益于其完善的皮肤科医疗基础设施、消费者认知度的提升以及品牌在微生物组护肤领域的投入。各公司正在零售、临床和健康管道部署平台，以满足消费者对屏障修护和针对特定皮肤问题的产品的需求。对微生物组研发、网红行销以及与皮肤科医生合作的投资，有助于推动创新并建立信任。领先品牌、研究机构和监管机构的积极参与，正在推动生态系统的深化和应用。各公司正在将微生物组策略与清洁美容、健康和皮肤健康目标结合。这些因素共同推动了北美在微生物组护肤商业化和平台部署方面的主导地位。

年复合成长率最高的地区：

预计亚太地区在预测期内将实现最高的复合年增长率。韩国、日本、中国和印度等国家正在拓展其在痤疮、抗衰老和敏感肌肤领域的平台。政府支持计画正在扶持护肤Start-Ups的生物技术孵化、成分创新和化妆品出口。本地供应商提供符合当地文化、行动优先且以健康为导向的解决方案，以满足不同肤质和习惯的需求。年轻消费者、老年人以及注重健康的都市区消费者对温和、全面且对微生物群安全的护肤产品的需求日益增长。这些趋势正在推动亚太地区微生物群护肤领域的创新和基础设施建设。

免费客製化服务

订阅本报告的用户可从以下免费自订选项中选择一项：

  • 公司简介
    • 对最多三家其他公司进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣对主要国家进行市场估算、预测和复合年增长率分析（註：基于可行性检查）
  • 竞争基准化分析
    • 基于产品系列、地域覆盖和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 引言

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 分析方法
  • 分析材料
    • 原始研究资料
    • 二手研究资讯来源
    • 先决条件

第三章 市场趋势分析

  • 介绍
  • 司机
  • 抑制因素
  • 市场机会
  • 威胁
  • 产品分析
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代产品的威胁
  • 新参与企业的威胁
  • 公司间的竞争

5. 全球微生物组护肤品市场（依产品划分）

  • 介绍
  • 美容精华液
  • 乳霜和乳液
  • 面具
  • 洁面乳
  • 爽肤水
  • 防晒油
  • 其他产品

6. 全球微生物组护肤品市场（依成分类型划分）

  • 介绍
  • 益生菌
  • 益生元
  • 后生元
  • 合益素
  • 对微生物群友善的活性成分
  • 发酵食品
  • 其他成分类型

7. 全球微生物组护肤品市场（依通路划分）

  • 介绍
  • 大卖场和超级市场
  • 专卖店
  • 电子商务平台
  • 皮肤科诊所
  • 其他分销管道

8. 全球微生物组护肤产品市场（依应用划分）

  • 介绍
  • 痤疮预防
  • 抗衰老
  • 水合作用和屏障修復
  • 消炎（药）
  • 其他用途

9. 全球微生物组护肤产品市场（依最终用户划分）

  • 介绍
  • 女士
  • 男性
  • 男女通用的
  • 儿童和青少年

第十章 全球微生物组护肤品市场（依地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章：主要趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併（M&A）
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章：公司简介

  • Mother Dirt Inc.
  • Gallinee Ltd.
  • BiomeSense Inc.
  • YUN Probiotherapy BV
  • S-Biomedic NV
  • AOBiome LLC
  • Esse Skincare Pty Ltd.
  • Dr. Ohhira Probiotics
  • TULA Life LLC
  • Amalthea Bio Inc.
  • Sequential Skin Ltd.
  • Biomilk Skincare Inc.
  • SkinBioTherapeutics plc
  • AxisBiotix Ltd.
  • Symbiome Inc.
Product Code: SMRC32222

According to Stratistics MRC, the Global Microbiome Skincare Products Market is accounted for $1.90 billion in 2025 and is expected to reach $6.00 billion by 2032 growing at a CAGR of 17.8% during the forecast period. Microbiome skincare products are formulations designed to maintain and restore the natural balance of microorganisms, such as bacteria, fungi, and viruses that live on the skin's surface. These products support a healthy skin microbiome, which plays a crucial role in protecting against pathogens, regulating inflammation, and maintaining the skin barrier. By using prebiotics, probiotics, and postbiotics, microbiome skincare helps nurture beneficial microbes while minimizing harmful ones. This approach enhances skin resilience, hydration, and overall health, making it suitable for sensitive, acne-prone, or aging skin. The goal is to achieve harmony between skin and its living ecosystem for optimal function and appearance.

Market Dynamics:

Driver:

Advances in micro-biome science, testing & formulation technologies

Researchers are uncovering links between skin microbiota and conditions such as acne eczema and aging which is driving demand for targeted solutions. Platforms support prebiotic probiotic and postbiotic ingredients that restore balance and strengthen the skin barrier. Integration with omics testing AI formulation and personalized skincare enhances efficacy and differentiation. Demand for science-backed gentle and barrier-supporting products is rising across dermatology wellness and beauty segments. These dynamics are propelling platform deployment across microbiome-driven skincare ecosystems.

Restraint:

Consumer confusion and skepticism about claims

Many users struggle to understand ingredient functions product mechanisms and clinical relevance which reduces engagement and loyalty. Enterprises face challenges in communicating benefits validating efficacy and differentiating from conventional skincare. Lack of standardized labeling third-party certification and education further complicates adoption and credibility. Vendors must invest in transparent messaging clinical trials and dermatologist partnerships to build trust. These constraints continue to hinder platform maturity across awareness-sensitive and science-dependent skincare markets.

Opportunity:

Growing prevalence of skin conditions and interest in barrier

Consumers are increasingly seeking solutions for acne sensitivity dryness and inflammation linked to microbiome imbalance. Platforms offer barrier-strengthening hydration and anti-inflammatory benefits using targeted microbial ingredients. Integration with wellness routines teledermatology and lifestyle diagnostics enhances personalization and impact. Demand for gentle inclusive and clinically validated products is rising across youth aging and sensitive skin segments. These trends are fostering growth across barrier-focused and condition-responsive microbiome skincare platforms.

Threat:

Regulatory uncertainty and lack of harmonized guidelines

Definitions of probiotics prebiotics and postbiotics vary across regions which complicates formulation and marketing. Enterprises face challenges in meeting cosmetic drug and supplement regulations while maintaining innovation and speed to market. Lack of harmonized standards and microbiome-specific frameworks further delays approvals and cross-border scaling. Vendors must engage with regulators invest in safety dossiers and align with emerging microbiome certification bodies to reduce risk. These limitations continue to constrain platform performance across compliance-sensitive and multi-jurisdictional skincare markets.

Covid-19 Impact:

The pandemic accelerated interest in skin health immunity and wellness which boosted microbiome skincare adoption across global markets. Lockdowns disrupted salon visits and increased demand for at-home barrier-supporting and stress-responsive skincare. Platforms scaled rapidly to offer probiotic serums microbiome-friendly cleansers and digital skin diagnostics. Investment in e-commerce teledermatology and personalized skincare surged across brands retailers and startups. Public awareness of skin microbiota and its role in inflammation and resilience increased across media and consumer circles. These shifts are reinforcing long-term investment in microbiome-enabled and wellness-aligned skincare infrastructure.

The probiotics segment is expected to be the largest during the forecast period

The probiotics segment is expected to account for the largest market share during the forecast period due to their versatility efficacy and consumer familiarity across microbiome skincare. Platforms use live or lysed bacteria to support barrier function reduce inflammation and improve skin texture. Integration with serums masks and moisturizers enhances delivery and routine compatibility. Demand for clinically validated gentle and microbiome-balancing products is rising across acne aging and sensitive skin segments. Vendors offer strain-specific formulations dermatologist-backed claims and transparent sourcing to support adoption. These capabilities are boosting segment dominance across probiotic-driven skincare platforms.

The anti-acne segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the anti-acne segment is predicted to witness the highest growth rate as microbiome platforms expand across inflammation control sebum regulation and barrier repair. Products target acne-causing bacteria while preserving beneficial microbes to reduce irritation and recurrence. Platforms support spot treatments cleansers and serums tailored to hormonal stress and lifestyle-linked acne. Integration with teledermatology wearable diagnostics and personalized routines enhances efficacy and engagement. Demand for non-antibiotic gentle and microbiome-safe solutions is rising across teens adults and post-pandemic skincare consumers. These dynamics are accelerating growth across anti-acne-focused microbiome skincare platforms and services.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to its dermatology infrastructure consumer awareness and brand investment across microbiome skincare. Enterprises deploy platforms across retail clinical and wellness channels to meet demand for barrier-supporting and condition-responsive products. Investment in microbiome R&D influencer marketing and dermatologist partnerships supports innovation and trust. Presence of leading brands research institutions and regulatory engagement drives ecosystem depth and adoption. Firms align microbiome strategies with clean beauty wellness and skin health goals. These factors are propelling North America's leadership in microbiome skincare commercialization and platform deployment.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR Countries like South Korea Japan China and India scale platforms across acne aging and sensitive skin segments. Government-backed programs support biotech incubation ingredient innovation and cosmetic exports across skincare startups. Local providers offer culturally adapted mobile-first and wellness-aligned solutions tailored to diverse skin types and routines. Demand for gentle inclusive and microbiome-safe skincare is rising across urban youth aging populations and wellness consumers. These trends are accelerating regional growth across Asia Pacific's microbiome skincare innovation and infrastructure.

Key players in the market

Some of the key players in Microbiome Skincare Products Market include Mother Dirt Inc., Gallinee Ltd., BiomeSense Inc., YUN Probiotherapy BV, S-Biomedic NV, AOBiome LLC, Esse Skincare Pty Ltd., Dr. Ohhira Probiotics, TULA Life LLC, Amalthea Bio Inc., Sequential Skin Ltd., Biomilk Skincare Inc., SkinBioTherapeutics plc, AxisBiotix Ltd. and Symbiome Inc.

Key Developments:

In October 2025, AOBiome Therapeutics partnered with Veristat, a global clinical research organization, to present at the Clinical Outsourcing Group - Bay Area 2025. The collaboration focused on optimizing sponsor-CRO relationships for microbiome-based clinical trials, particularly those targeting inflammatory skin conditions using ammonia-oxidizing bacteria (AOB) platforms.

In June 2025, YUN Probiotherapy BV entered a strategic partnership with Bausch Health Companies Inc. to introduce its probiotic-based skincare products to the Polish market. The collaboration focused on acne-prone skin solutions and marked YUN's first major commercial expansion in Eastern Europe, with plans for broader rollout across the region.

Products Covered:

  • Skincare
  • Haircare
  • Makeup
  • Other Products

Ingredient Types Covered:

  • Probiotics
  • Prebiotics
  • Postbiotics
  • Synbiotics
  • Microbiome-Friendly Actives
  • Fermented Ingredients
  • Other Ingredient Types

Distribution Channels Covered:

  • Hypermarkets and Supermarkets
  • Specialty Stores
  • E-commerce Platforms
  • Dermatology Clinics
  • Other Distribution Channels

Applications Covered:

  • Anti-Acne
  • Anti-Aging
  • Hydration and Barrier Repair
  • Anti-Inflammatory
  • Other Applications

End Users Covered:

  • Women
  • Men
  • Unisex
  • Children and Teenagers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Microbiome Skincare Products Market, By Product

  • 5.1 Introduction
  • 5.2 Serums
  • 5.3 Creams and Lotions
  • 5.4 Masks
  • 5.5 Cleansers
  • 5.6 Toners
  • 5.7 Sunscreens
  • 5.8 Other Products

6 Global Microbiome Skincare Products Market, By Ingredient Type

  • 6.1 Introduction
  • 6.2 Probiotics
  • 6.3 Prebiotics
  • 6.4 Postbiotics
  • 6.5 Synbiotics
  • 6.6 Microbiome-Friendly Actives
  • 6.7 Fermented Ingredients
  • 6.8 Other Ingredient Types

7 Global Microbiome Skincare Products Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Hypermarkets and Supermarkets
  • 7.3 Specialty Stores
  • 7.4 E-commerce Platforms
  • 7.5 Dermatology Clinics
  • 7.6 Other Distribution Channels

8 Global Microbiome Skincare Products Market, By Application

  • 8.1 Introduction
  • 8.2 Anti-Acne
  • 8.3 Anti-Aging
  • 8.4 Hydration and Barrier Repair
  • 8.5 Anti-Inflammatory
  • 8.6 Other Applications

9 Global Microbiome Skincare Products Market, By End User

  • 9.1 Introduction
  • 9.2 Women
  • 9.3 Men
  • 9.4 Unisex
  • 9.5 Children and Teenagers

10 Global Microbiome Skincare Products Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Mother Dirt Inc.
  • 12.2 Gallinee Ltd.
  • 12.3 BiomeSense Inc.
  • 12.4 YUN Probiotherapy BV
  • 12.5 S-Biomedic NV
  • 12.6 AOBiome LLC
  • 12.7 Esse Skincare Pty Ltd.
  • 12.8 Dr. Ohhira Probiotics
  • 12.9 TULA Life LLC
  • 12.10 Amalthea Bio Inc.
  • 12.11 Sequential Skin Ltd.
  • 12.12 Biomilk Skincare Inc.
  • 12.13 SkinBioTherapeutics plc
  • 12.14 AxisBiotix Ltd.
  • 12.15 Symbiome Inc.

List of Tables

  • Table 1 Global Microbiome Skincare Products Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Microbiome Skincare Products Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Microbiome Skincare Products Market Outlook, By Serums (2024-2032) ($MN)
  • Table 4 Global Microbiome Skincare Products Market Outlook, By Creams and Lotions (2024-2032) ($MN)
  • Table 5 Global Microbiome Skincare Products Market Outlook, By Masks (2024-2032) ($MN)
  • Table 6 Global Microbiome Skincare Products Market Outlook, By Cleansers (2024-2032) ($MN)
  • Table 7 Global Microbiome Skincare Products Market Outlook, By Toners (2024-2032) ($MN)
  • Table 8 Global Microbiome Skincare Products Market Outlook, By Sunscreens (2024-2032) ($MN)
  • Table 9 Global Microbiome Skincare Products Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 10 Global Microbiome Skincare Products Market Outlook, By Ingredient Type (2024-2032) ($MN)
  • Table 11 Global Microbiome Skincare Products Market Outlook, By Probiotics (2024-2032) ($MN)
  • Table 12 Global Microbiome Skincare Products Market Outlook, By Prebiotics (2024-2032) ($MN)
  • Table 13 Global Microbiome Skincare Products Market Outlook, By Postbiotics (2024-2032) ($MN)
  • Table 14 Global Microbiome Skincare Products Market Outlook, By Synbiotics (2024-2032) ($MN)
  • Table 15 Global Microbiome Skincare Products Market Outlook, By Microbiome-Friendly Actives (2024-2032) ($MN)
  • Table 16 Global Microbiome Skincare Products Market Outlook, By Fermented Ingredients (2024-2032) ($MN)
  • Table 17 Global Microbiome Skincare Products Market Outlook, By Other Ingredient Types (2024-2032) ($MN)
  • Table 18 Global Microbiome Skincare Products Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 19 Global Microbiome Skincare Products Market Outlook, By Hypermarkets and Supermarkets (2024-2032) ($MN)
  • Table 20 Global Microbiome Skincare Products Market Outlook, By Specialty Stores (2024-2032) ($MN)
  • Table 21 Global Microbiome Skincare Products Market Outlook, By E-commerce Platforms (2024-2032) ($MN)
  • Table 22 Global Microbiome Skincare Products Market Outlook, By Dermatology Clinics (2024-2032) ($MN)
  • Table 23 Global Microbiome Skincare Products Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
  • Table 24 Global Microbiome Skincare Products Market Outlook, By Application (2024-2032) ($MN)
  • Table 25 Global Microbiome Skincare Products Market Outlook, By Anti-Acne (2024-2032) ($MN)
  • Table 26 Global Microbiome Skincare Products Market Outlook, By Anti-Aging (2024-2032) ($MN)
  • Table 27 Global Microbiome Skincare Products Market Outlook, By Hydration and Barrier Repair (2024-2032) ($MN)
  • Table 28 Global Microbiome Skincare Products Market Outlook, By Anti-Inflammatory (2024-2032) ($MN)
  • Table 29 Global Microbiome Skincare Products Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 30 Global Microbiome Skincare Products Market Outlook, By End User (2024-2032) ($MN)
  • Table 31 Global Microbiome Skincare Products Market Outlook, By Women (2024-2032) ($MN)
  • Table 32 Global Microbiome Skincare Products Market Outlook, By Men (2024-2032) ($MN)
  • Table 33 Global Microbiome Skincare Products Market Outlook, By Unisex (2024-2032) ($MN)
  • Table 34 Global Microbiome Skincare Products Market Outlook, By Children and Teenagers (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.